Today, Folia Health and Novartis Pharmaceuticals, Inc. proudly announce their collaboration on an innovative, at-home ...

Arrowhead Pharmaceuticals’ phase 1/2a study has found the company’s investigational RNA interference (RNAi) candidate was ...

StockNews.com upgraded shares of Omeros (NASDAQ:OMER – Free Report) from a sell rating to a hold rating in a research note released on Thursday. OMER has been the subject of several other reports.

A Leigh flat that has been a magnet for anti-social behaviour and neighbour complaints has been hit with a closure order.

aimed at treating IgA nephropathy (IgAN), a kidney disease. The Phase 1/2 study demonstrated significant reductions in key markers of disease activity and proteinuria, a sign of kidney damage.

The Ogun State government has approved reconstruction of 11 roads, spread across the three senatorial districts in the state.

Haseeb Ahmad brings over 25 years of leadership experience in life sciences, most recently serving as President of Novartis ...

BIIB's TRANSCEND phase III study on felzartamab in adult kidney transplant recipients diagnosed with late AMR is set to enroll approximately 120 patients.

Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on March 6, 2025, the Compensation Committee granted inducement ...

Wigan Warriors star Luke Thompson is keen to make more memories in the Challenge Cup having experienced the highs and lows at ...

Travere Therapeutics' Filspari boosts revenue with FDA approval, but heavy losses and competitive threats raise concerns for ...